The Prognostic and Diagnostic Value of [
MTV
PET/CT
TLG
[18F]FDG PET/CT vs. neck MRI
laryngeal squamous-cell carcinoma
metastatic lymph node
semiquantitative PET parameters
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
17 May 2023
17 May 2023
Historique:
received:
09
03
2023
revised:
06
04
2023
accepted:
10
05
2023
medline:
27
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
This study aims to determine the diagnostic accuracy of staging PET/CT and neck MRI in patients with laryngeal carcinoma and to assess the value of PET/CT in predicting progression-free survival (PFS) and overall survival (OS). Sixty-eight patients who had both modalities performed before treatment between 2014 and 2021 were included in this study. The sensitivity and specificity of PET/CT and MRI were evaluated. PET/CT had 93.8% sensitivity, 58.3% specificity, and 75% accuracy for nodal metastasis, whereas MRI had 68.8%, 61.1%, and 64.7% accuracy, respectively. At a median follow-up of 51 months, 23 patients had developed disease progression and 17 patients had died. Univariate-survival analysis revealed all utilized PET parameters as significant prognostic factors for OS and PFS (
Identifiants
pubmed: 37240619
pii: jcm12103514
doi: 10.3390/jcm12103514
pmc: PMC10218884
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Otolaryngol Head Neck Surg. 2007 Jul;137(1):130-7
pubmed: 17599580
Surg Oncol. 2013 Jun;22(2):e11-6
pubmed: 23538049
AJNR Am J Neuroradiol. 2010 Apr;31(4):598-604
pubmed: 19910448
PET Clin. 2022 Apr;17(2):235-248
pubmed: 35260366
Clin Lung Cancer. 2018 Jan;19(1):e101-e108
pubmed: 28690012
J Nucl Med. 2014 Jun;55(6):884-90
pubmed: 24752671
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1360-75
pubmed: 26780912
Medicine (Baltimore). 2021 Oct 8;100(40):e27427
pubmed: 34622853
Aging (Albany NY). 2020 Jul 16;12(14):14593-14619
pubmed: 32674074
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Jul-Aug;40(4):229-238
pubmed: 34218885
CA Cancer J Clin. 2017 Mar;67(2):122-137
pubmed: 28128848
Eur J Cancer. 2005 Mar;41(5):683-93
pubmed: 15763643
J Nucl Med. 2017 Dec;58(12):1919-1924
pubmed: 28572489
AJR Am J Roentgenol. 2017 Aug;209(2):289-303
pubmed: 28731808
Laryngoscope. 2018 Feb;128(2):378-385
pubmed: 28600822
J Natl Cancer Inst. 2008 May 21;100(10):712-20
pubmed: 18477804
Nucl Med Commun. 2018 Apr;39(4):334-342
pubmed: 29533345
J Nucl Med. 2011 Feb;52(2):180-7
pubmed: 21270454
Semin Ultrasound CT MR. 2019 Oct;40(5):376-390
pubmed: 31635765
Int J Biol Sci. 2021 Jan 1;17(2):475-486
pubmed: 33613106
Acta Otolaryngol. 2010 Jul;130(7):756-62
pubmed: 20085442
Oral Oncol. 2015 Apr;51(4):314-20
pubmed: 25619735
EJNMMI Res. 2019 Feb 7;9(1):14
pubmed: 30734113
PLoS One. 2022 Feb 25;17(2):e0264387
pubmed: 35213602
Radiology. 2014 Apr;271(1):153-61
pubmed: 24475791
CA Cancer J Clin. 2017 Jan;67(1):31-50
pubmed: 27898173
J Oncol. 2009;2009:208725
pubmed: 19707528
PLoS One. 2014 May 12;9(5):e96999
pubmed: 24818750
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):129-36
pubmed: 15629603
Nucl Med Commun. 2019 Apr;40(4):361-369
pubmed: 30664599
Clin Radiol. 2021 Jan;76(1):78.e9-78.e17
pubmed: 33036778
J Clin Oncol. 2018 Apr 10;36(11):1143-1169
pubmed: 29172863
Head Neck. 2016 Feb;38(2):290-3
pubmed: 25327765
Oral Oncol. 2009 Mar;45(3):234-40
pubmed: 18715818
BMC Med Imaging. 2023 Feb 22;23(1):34
pubmed: 36814217
Radiat Oncol. 2023 Jan 30;18(1):20
pubmed: 36710364
Oral Oncol. 2007 Oct;43(9):887-93
pubmed: 17207656